Compass Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
KROS
Keros Therapeutics, Inc. |
$13.49 | $553.99 M | -80.24 | 163 |
KRON
Kronos Bio, Inc. |
$0.88 | $53.65 M | -0.82 | 8 |
MGTX
MeiraGTx Holdings plc |
$6.61 | $524.79 M | -2.83 | 375 |
CGEM
Cullinan Oncology, Inc. |
$7.76 | $457.36 M | -2.8 | 111 |
GOSS
Gossamer Bio, Inc. |
$1.25 | $306.86 M | -6.14 | 144 |
ANAB
AnaptysBio, Inc. |
$22.47 | $660.47 M | -4.72 | 136 |
MLTX
MoonLake Immunotherapeutics |
$47.52 | $3.01 B | -20.6 | 100 |
FIXX
Homology Medicines, Inc. |
$1.56 | $3.02 M | -0.03 | 7 |
GPCR
Structure Therapeutics Inc. |
$21.08 | $1.25 B | -8.41 | 163 |
AVTE
Aerovate Therapeutics, Inc. |
$9.19 | $77.68 M | -0.05 | 4 |
ELVN
Enliven Therapeutics, Inc. |
$20.68 | $1.23 B | -11.19 | 62 |
IDYA
IDEAYA Biosciences, Inc. |
$21.37 | $1.93 B | -6.04 | 131 |
TYRA
Tyra Biosciences, Inc. |
$9.10 | $512.10 M | -5.91 | 60 |
NAMS
NewAmsterdam Pharma Company N.V. |
$18.57 | $2.05 B | -9.94 | 68 |
NVCT
Nuvectis Pharma, Inc. |
$7.55 | $161.30 M | -6.83 | 13 |
REPL
Replimune Group, Inc. |
$9.33 | $729.24 M | -3.08 | 479 |
PEPG
PepGen Inc. |
$1.15 | $44.50 M | -0.43 | 79 |
LYRA
Lyra Therapeutics, Inc. |
$9.11 | $16.31 M | -0.2 | 30 |
VIGL
Vigil Neuroscience, Inc. |
$7.95 | $370.81 M | -3.86 | 69 |
GLUE
Monte Rosa Therapeutics, Inc. |
$4.60 | $292.79 M | 39.67 | 142 |
IVA
Inventiva S.A. |
$3.08 | $159.58 M | -0.87 | 114 |
PRTC
PureTech Health plc |
$17.48 | $408.32 M | 8.1 | 80 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
